Drugs / Clenil® Modulite® via AeroChamber Plus™
Clenil® Modulite® via AeroChamber Plus™
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01370031 | Apr → Jun 2011 | asthma | Chiesi Farmaceutici S.p.A. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Clenil Modulite via AeroChamber Plus | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01370031 ↗ |
| Known as | BDP | “after inhalation of BDP (Clenil® Modulite®) with the AeroChamber Plus™ spacer device” NCT01370031 ↗ |
| Known as | Clenil Modulite | “Beclomethasone Dipropionate (Clenil® Modulite®) 250 µg HFA pMDI” NCT01370031 ↗ |